Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
USP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SETD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKI55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ADAM22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFT2D3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC286437 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNASEH2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CDC42BPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506730 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADARB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SORL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on